Kenji Ikezawa

41PUBLICATIONS
72CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Clinical nutritionPredictive and prognostic markersDisease surveillanceLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (41)

|Sep 14, 2026
Prospective Phase II Trial of Biweekly Gemcitabine Plus Nab-Paclitaxel as First-Line Therapy in Patients Aged 75 Years and Older With Unresectable Pancreatic Cancer.

|Jul 04, 2026
Association between response to gemcitabine-based neoadjuvant therapy and efficacy of gemcitabine plus nab-paclitaxel for recurrent pancreatic ductal adenocarcinoma.

|Mar 10, 2026
Effects of Pancreatic Duct Stenting on Nutrition and Pancreatic Function in Unresectable Pancreatic Cancer: A Pilot Study.

Ko Watsuji, Kenji Ikezawa, Yugo Kai

|Feb 11, 2026
Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden-High Unresectable Pancreatic Cancer and the Efficacy of Pembrolizumab Treatment.

Yugo Kai, Kenji Ikezawa, Kazuhiro Kozumi

|Jan 27, 2026
Impact of Prior Treatment History on Recurrence After Complete Response to Atezolizumab Plus Bevacizumab in Unresectable Hepatocellular Carcinoma.

Tasuku Nakabori, Masaki Kawabata, Kaori Mukai

|Oct 23, 2025
Comparative Evaluation of Percutaneous Transhepatic Biliary Drainage and Endoscopic Ultrasound-Guided Biliary Drainage for Preoperative Management of Malignant Distal Bile Duct Obstruction After Failed ERCP: A Multicenter Retrospective Analysis.

Masahiro Itonaga, Mamoru Takenaka, Hideyuki Shiomi

Pageof 7

Frequent Collaborators

9 joint publications

Ryoji Takada

7 joint publications

Tasuku Nakabori

6 joint publications

Takuo Yamai

4 joint publications

Mamoru Takenaka